Table 3 Improvement in symptoms and HQOL 6Â months postoperatively
| Â | Improvement Group 1 | Improvement Group 2 | Improvement Group 3 | Comparing 1 vs 2 p | Comparing 1 vs 3 p | Comparing 2 vs 3 p |
|---|---|---|---|---|---|---|
Symptoms - VAS | ||||||
 Nasal obstruction | 40,5 (33.5) | 44.6 (25.7) | 29.5 (31.5) | 0,39 | 0,04 | 0,01 |
 Nasal discharge | 19.3 (30.5) | 17.4 (29.5) | 12.0 (33.9) | 0,86 | 0,15 | 0,20 |
 Sneezing | 12.9 (32.4) | 14.4 (26.6) | 5.48 (20.7) | 0,40 | 0,14 | 0,01 |
 Snoring | 27.7 (35.0) | 26.0 (28.0) | 12.9 (28.3) | 0,55 | 0,01 | 0,01 |
 Oral breathing | 40.1 (35.4) | 37.2 (32.3) | 19.9 (29.4) | 0,50 | 0,01 | 0,01 |
 Reduced general health | 33.2 (33.5) | 32.0 (29.1) | 22.0 (32.7) | 0,99 | 0,06 | 0,06 |
HQOL - SNOT- 20 | ||||||
 Total SNOT 20 | 0.61 (0.68) | 0.78 (0.84) | 0.44 (0.72) | 0,30 | 0,15 | 0,01 |
Subset | ||||||
 Rhinologic | 0.66 (1.08) | 0.65 (1.09) | 0.40 (0.90) | 0,95 | 0,28 | 0,11 |
 Ear/facial | 0.28 (0.62) | 0.55 (0.84) | 0.32 (0.88) | 0,06 | 0,42 | 0,32 |
 Sleep | 0.92 (1.18) | 1.08 (1.36) | 0.59 (1.33) | 0,82 | 0,05 | 0,03 |
 Psychological | 0.63 (0.97) | 0.87 (1.01) | 0.50 (1.00) | 0,12 | 0,63 | 0,04 |
HQOL - SF-36 | ||||||
 PF physical functioning | 2.17 (10.3) | 4.42 (15.7) | 3.17 (20.2) | 0,69 | 0,65 | 0,41 |
 RP role-physical | 6.86 (19.9) | 9.55 (24.8) | 2.91 (21.2) | 0,57 | 0,48 | 0,22 |
 BP bodily pain | 5.42 (22.8) | 5.82 (27.0) | 3.74 (22.5) | 0,71 | 0,38 | 0,66 |
 GH general health | 4.49 (18.8) | 5.14 (15.7) | 5.10 (16.4) | 0,99 | 0,84 | 0,77 |
 VT vitality | 5.00 (16.0) | 8.00 (16.3) | 8.25 (16.8) | 0,35 | 0,37 | 0,99 |
 SF social functioning | 5.70 (18.5) | 3.57 (18.9) | 5.39 (24.0) | 0,66 | 0,76 | 0,50 |
 RE role-emotional | 5.12 (20.2) | 2.46 (21.8) | 0.00 (19.7) | 0,64 | 0,85 | 0,43 |
 MH general mental health | 1.96 (9.94) | 2.54 (8.69) | 1.43 (11.0) | 0,61 | 0,89 | 0,74 |
 Physical health summary | 4.44 (12.9) | 6.08 (16.1) | 3.80 (14.0) | 0,74 | 0,59 | 0,59 |
 Mental health summary | 4.91 (12.9) | 4.33 (12.1) | 4.69 (14.6) | 0,83 | 0,94 | 0,93 |